Cannabics Pharmaceuticals

Investor Relations

  ( )


Cannabics Pharmaceuticals Inc. (CNBX) is a US bio-pharma company dedicated to developing precision medicine personalized anti-cancer diagnostics and cannabis based treatments. It is based on Israeli R&D licensed by the Israeli Ministry of Health for scientific and clinical research. Cannabics novel technology pioneers the assimilation of precision medicine into Cannabinoid-based therapies for cancer patients, utilizing original, patented screening technologies, data management and artificial intelligence (AI).

Financial Reports

All articles loaded
No more articles to load

Stock Quote


Mail Alert

Subscribe to Receive Notifications by Email